نتائج البحث - Yingyi Yu
- يعرض 1 - 2 نتائج من 2
-
1
High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia حسب Yu Hou, Qi Feng, Miao Xu, Guosheng Li, Xuena Liu, Zi Sheng, Hai Zhou, Ji Ma, Yu Wei, Yuanxin Sun, Yingyi Yu, Jihua Qiu, Linlin Shao, Xinguang Liu, Ming Hou, Jun Peng
منشور في 2016Artigo -
2
Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial حسب Mei-feng Li, Xiaoli Li, Kai-liang Fan, Yingyi Yu, Jing Gong, Shu-ying Geng, Yafeng Liang, Ling Huang, Jihua Qiu, Xinghan Tian, Wenting Wang, Xiaolu Zhang, Qingxia Yu, Yuanfeng Zhang, Peng Lin, Lina Wang, Xin Li, Ming Hou, Luyi Liu, Jun Peng
منشور في 2017Artigo
أدوات البحث:
موضوعات ذات صلة
Internal medicine
Medicine
Platelet
Cancer
Cancer research
Coronavirus disease 2019 (COVID-19)
Dexamethasone
Disease
Immune system
Immune thrombocytopenia
Immunology
Infectious disease (medical specialty)
Interquartile range
Mechanism (biology)
Myeloid
Myeloid-derived Suppressor Cell
Oseltamivir
Pathogenesis
Physics
Prospective cohort study
Quantum mechanics
Randomization
Randomized controlled trial
Sepsis
Septic shock
Suppressor